| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh School of Medicine (L.A.B., J.P.), Pittsburgh, Pennsylvania 15261; and the Department of Medicine and Physiology, Dartmouth Medical School (D.L.S.G.), Lebanon, New Hampshire 03756
Address all correspondence and requests for reprints to: Dr. Lynn A. Burmeister, Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261
The type 2 5'-deiodinase (D2) appears to play an important role in maintaining the intracerebral T3 content relatively constant during changes in thyroidal state. Previous studies have demonstrated that the regulation of this enzyme by thyroid hormone and its analogs occurs at a posttranslational level. The availability of the rat D2 complementary DNA now allows an assessment of whether pretranslational regulation of this enzyme also occurs in the cerebral cortex. In rats rendered hypothyroid by the addition of methimazole to the drinking water, D2 messenger RNA (mRNA) is increased 70% (P = 0.03). Treatment with L-T3 (50 µg/100 g BW) for 4 days results in an 80% decrease in D2 mRNA compared with that in euthyroid controls (P < 0.001). Administration of lower doses of L-T3 (0.253 µg/100 g BW·day) is associated with a dose-dependent decrease in cortical D2 mRNA, but little or no change in D2 activity. The decrease in D2 mRNA in response to T3 treatment can be demonstrated within 4 h. Treatment of hypothyroid rats for 2 weeks with graded doses of L-T4 (0.11.5 µg/100 g BW·day) results in a significant decrease in cortical D2 activity, but not mRNA. The association between D2 activity and D2 mRNA in euthyroid, hypothyroid, and hormone-treated rats across a full range of thyroidal states suggests that L-T4 treatment is associated with greater changes in cortical D2 activity (via posttranslational effects) than mRNA, whereas L-T3 treatment has a greater effect on decreasing D2 mRNA (i.e. pretranslational effects). In conclusion, these studies demonstrate both pre- and posttranslational regulation of cortical D2 expression. The relative contribution of each mechanism depends on the ambient thyroid hormone concentration.
This article has been cited by other articles:
![]() |
C. Fekete, B. C. G. Freitas, A. Zeold, G. Wittmann, A. Kadar, Z. Liposits, M. A. Christoffolete, P. Singru, R. M. Lechan, A. C. Bianco, et al. Expression Patterns of WSB-1 and USP-33 Underlie Cell-Specific Posttranslational Control of Type 2 Deiodinase in the Rat Brain Endocrinology, October 1, 2007; 148(10): 4865 - 4874. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S Wagner, S. M Wajner, J. M Dora, and A. L. Maia Regulation of Dio2 gene expression by thyroid hormones in normal and type 1 deiodinase-deficient C3H mice J. Endocrinol., June 1, 2007; 193(3): 435 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kanou, A. Hishinuma, K. Tsunekawa, K. Seki, Y. Mizuno, H. Fujisawa, T. Imai, Y. Miura, T. Nagasaka, C. Yamada, et al. Thyroglobulin Gene Mutations Producing Defective Intracellular Transport of Thyroglobulin Are Associated with Increased Thyroidal Type 2 Iodothyronine Deiodinase Activity J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1451 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont Selenium, the Thyroid, and the Endocrine System Endocr. Rev., December 1, 2005; 26(7): 944 - 984. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y Chan, M. H Andrews, R. Lingas, C. J McCabe, J. A Franklyn, M. D Kilby, and S. G Matthews Maternal nutrient deprivation induces sex-specific changes in thyroid hormone receptor and deiodinase expression in the fetal guinea pig brain J. Physiol., July 15, 2005; 566(2): 467 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kalsbeek, R. M. Buijs, R. van Schaik, E. Kaptein, T. J. Visser, B. Z. Doulabi, and E. Fliers Daily Variations in Type II Iodothyronine Deiodinase Activity in the Rat Brain as Controlled by the Biological Clock Endocrinology, March 1, 2005; 146(3): 1418 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Zavacki, H. Ying, M. A. Christoffolete, G. Aerts, E. So, J. W. Harney, S.-y. Cheng, P. R. Larsen, and A. C. Bianco Type 1 Iodothyronine Deiodinase Is a Sensitive Marker of Peripheral Thyroid Status in the Mouse Endocrinology, March 1, 2005; 146(3): 1568 - 1575. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yasuzawa-Amano, N. Toyoda, A. Maeda, A. Kosaki, Y. Mori, T. Iwasaka, and M. Nishikawa Expression and Regulation of Type 2 Iodothyronine Deiodinase in Rat Aorta Media Endocrinology, December 1, 2004; 145(12): 5638 - 5645. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. J. S. Wassen, W. Klootwijk, E. Kaptein, D. J. Duncker, T. J. Visser, and G. G. J. M. Kuiper Characteristics and Thyroid State-Dependent Regulation of Iodothyronine Deiodinases in Pigs Endocrinology, September 1, 2004; 145(9): 4251 - 4263. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gereben, J. Pachucki, A. Kollar, Z. Liposits, and C. Fekete Ontogenic Redistribution of Type 2 Deiodinase Messenger Ribonucleic Acid in the Brain of Chicken Endocrinology, August 1, 2004; 145(8): 3619 - 3625. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sugiyama, H. Kusuhara, H. Taniguchi, S. Ishikawa, Y. Nozaki, H. Aburatani, and Y. Sugiyama Functional Characterization of Rat Brain-specific Organic Anion Transporter (Oatp14) at the Blood-Brain Barrier: HIGH AFFINITY TRANSPORTER FOR THYROXINE J. Biol. Chem., October 31, 2003; 278(44): 43489 - 43495. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Friedrichsen, S. Christ, H. Heuer, M. K. H. Schafer, A. Mansouri, K. Bauer, and T. J. Visser Regulation of Iodothyronine Deiodinases in the Pax8-/- Mouse Model of Congenital Hypothyroidism Endocrinology, March 1, 2003; 144(3): 777 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gereben, A. Kollar, J. W. Harney, and P. R. Larsen The mRNA Structure Has Potent Regulatory Effects on Type 2 Iodothyronine Deiodinase Expression Mol. Endocrinol., July 1, 2002; 16(7): 1667 - 1679. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Everson and T. S. Nowak Jr. Hypothalamic thyrotropin-releasing hormone mRNA responses to hypothyroxinemia induced by sleep deprivation Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E85 - E93. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Martinez-deMena, A. Hernandez, and M.-J. Obregon Triiodothyronine is required for the stimulation of type II 5'-deiodinase mRNA in rat brown adipocytes Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1119 - E1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases Endocr. Rev., February 1, 2002; 23(1): 38 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Peeters, C. Fekete, C. Goncalves, G. Legradi, H. M. Tu, J. W. Harney, A. C. Bianco, R. M. Lechan, and P. R. Larsen Regional physiological adaptation of the central nervous system deiodinases to iodine deficiency Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E54 - E61. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mizuma, M. Murakami, and M. Mori Thyroid Hormone Activation in Human Vascular Smooth Muscle Cells : Expression of Type II Iodothyronine Deiodinase Circ. Res., February 16, 2001; 88(3): 313 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Almeida Palha, R. Fernandes, G. Morreale de Escobar, V. Episkopou, M. Gottesman, and M. J. Saraiva Transthyretin Regulates Thyroid Hormone Levels in the Choroid Plexus, But Not in the Brain Parenchyma: Study in a Transthyretin-Null Mouse Model Endocrinology, September 1, 2000; 141(9): 3267 - 3272. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Canettieri, F. S. Celi, G. Baccheschi, L. Salvatori, M. Andreoli, and M. Centanni Isolation of Human Type 2 Deiodinase Gene Promoter and Characterization of a Functional Cyclic Adenosine Monophosphate Response Element Endocrinology, May 1, 2000; 141(5): 1804 - 1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Eravci, G. Pinna, H. Meinhold, and A. Baumgartner Effects of Pharmacological and Nonpharmacological Treatments on Thyroid Hormone Metabolism and Concentrations in Rat Brain Endocrinology, March 1, 2000; 141(3): 1027 - 1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Steinsapir, A. C. Bianco, C. Buettner, J. Harney, and P. R. Larsen Substrate-Induced Down-Regulation of Human Type 2 Deiodinase (hD2) Is Mediated through Proteasomal Degradation and Requires Interaction with the Enzyme's Active Center Endocrinology, March 1, 2000; 141(3): 1127 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pachucki, L. A. Burmeister, and P. R. Larsen Thyroid Hormone Regulates Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel (HCN2) mRNA in the Rat Heart Circ. Res., September 17, 1999; 85(6): 498 - 503. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hosoi, M. Murakami, H. Mizuma, T. Ogiwara, M. Imamura, and M. Mori Expression and Regulation of Type II Iodothyronine Deiodinase in Cultured Human Skeletal Muscle Cells J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3293 - 3300. [Abstract] [Full Text] |
||||
![]() |
S. Pallud, M. Ramaugé, J.-M. Gavaret, A.-M. Lennon, N. Munsch, D. L. St. Germain, M. Pierre, and F. Courtin Regulation of Type 3 Iodothyronine Deiodinase Expression in Cultured Rat Astrocytes: Role of the Erk Cascade Endocrinology, June 1, 1999; 140(6): 2917 - 2923. [Abstract] [Full Text] |
||||
![]() |
B. Gereben, T. Bartha, H. M. Tu, J. W. Harney, P. Rudas, and P. R. Larsen Cloning and Expression of the Chicken Type 2 Iodothyronine 5'-Deiodinase J. Biol. Chem., May 14, 1999; 274(20): 13768 - 13776. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Guadano-Ferraz, M. J. Escamez, E. Rausell, and J. Bernal Expression of Type 2 Iodothyronine Deiodinase in Hypothyroid Rat Brain Indicates an Important Role of Thyroid Hormone in the Development of Specific Primary Sensory Systems J. Neurosci., May 1, 1999; 19(9): 3430 - 3439. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Kim, J. W. Harney, and P. R. Larsen Studies of the Hormonal Regulation of Type 2 5'-Iodothyronine Deiodinase Messenger Ribonucleic Acid in Pituitary Tumor Cells Using Semiquantitative Reverse Transcription-Polymerase Chain Reaction Endocrinology, December 1, 1998; 139(12): 4895 - 4905. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Diano, F. Naftolin, F. Goglia, and T. L. Horvath Fasting-Induced Increase in Type II Iodothyronine Deiodinase Activity and Messenger Ribonucleic Acid Levels Is Not Reversed by Thyroxine in the Rat Hypothalamus Endocrinology, June 1, 1998; 139(6): 2879 - 2884. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |